Pharmaceutical manufacturing employment creation

The investment is expected to create 250 high-wage manufacturing jobs and approximately 200 construction jobs in Oregon during site development, with commercial operations expected to begin in 2031.

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA

Roche. (2026). Roche’s US subsidiary Genentech announces manufacturing expansion in the United States. Retrieved September 15, 2026, from https://www.roche.com/media/releases/med-cor-2026-08-20. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGER

Copy

MLA

Roche. "Roche’s US subsidiary Genentech announces manufacturing expansion in the United States." 2026, https://www.roche.com/media/releases/med-cor-2026-08-20. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGER.

Copy

Chicago

Roche. "Roche’s US subsidiary Genentech announces manufacturing expansion in the United States." 2026. https://www.roche.com/media/releases/med-cor-2026-08-20. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGER.

Copy

BibTeX

@misc{roche2026pharmaceuticalbjmger, author = {{Roche}}, title = {Roche’s US subsidiary Genentech announces manufacturing expansion in the United States}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGER}, note = {Original source: https://www.roche.com/media/releases/med-cor-2026-08-20. Accessed September 15, 2026.} }

Copy

Everything needed to check this number yourself, without taking our word for it.

Record last modified 15 September 2026. Value type: forecast. Update cadence: irregular. This page is permanently addressable at statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGER.